2 studies found for:    22592092 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia
Condition: HIV-1 Infection
Intervention: Drug: atazanavir 300 mg + ritonavir 100 mg + dolutegravir 50 mg
2 Terminated
Has Results
Phase IIB Pilot of Atazanavir + Raltegravir
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Raltegravir;   Drug: Ritonavir;   Drug: Tenofovir/Emtricitabine

Indicates status has not been verified in more than two years